These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2449616)

  • 21. Reversal of the neuroleptanalgesic effect of droperidolfentanyl in the dog by 4-aminopyridine and naloxone.
    Booth NH; Hatch RC; Crawford LM
    Am J Vet Res; 1982 Jul; 43(7):1227-31. PubMed ID: 6125116
    [No Abstract]   [Full Text] [Related]  

  • 22. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine.
    Henningfield JE; Miyasato K; Jasinski DR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):1-12. PubMed ID: 4009494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of morphine, pentazocine and ciramadol in postaddicts.
    Preston KL; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1987 Mar; 240(3):900-10. PubMed ID: 3559982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug discrimination in human postaddicts: agonist-antagonist opioids.
    Preston KL; Bigelow GE; Bickel WK; Liebson IA
    J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-choice discrimination in methadone maintenance patients: hydromorphone, naloxone, and saline.
    Preston KL; Bigelow GE; Stitzer ML; Liebson IA
    NIDA Res Monogr; 1984; 55():151-7. PubMed ID: 6085768
    [No Abstract]   [Full Text] [Related]  

  • 26. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.
    Alho H; Sinclair D; Vuori E; Holopainen A
    Drug Alcohol Depend; 2007 Apr; 88(1):75-8. PubMed ID: 17055191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rate.
    Belenky GL; Holaday JW
    Brain Res; 1979 Nov; 177(2):414-7. PubMed ID: 497843
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review.
    McCormick Z; Chu SK; Chang-Chien GC; Joseph P
    Pain Med; 2013 Aug; 14(8):1187-91. PubMed ID: 23647815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marijuana and amphetamine: the question of interaction.
    Zalcman S; Liskow B; Cadoret R; Goodwin D
    Am J Psychiatry; 1973 Jun; 130(6):707-8. PubMed ID: 4701964
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.
    Walsh SL; Sullivan JT; Preston KL; Garner JE; Bigelow GE
    J Pharmacol Exp Ther; 1996 Nov; 279(2):524-38. PubMed ID: 8930154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Per- and postoperative buprenorphine analgesia: cardiocirculatory and respiratory effects].
    Rifat K; Magnin C; Morel D
    Cah Anesthesiol; 1984; 32(1):33-6. PubMed ID: 6529632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of continuous monitoring of spontaneous respiration in the postoperative phase. 2. Cutaneous oxygen and carbon dioxide partial pressures following i.v. bolus application of fentanyl, buprenorphine, naloxone and amiphenazole in healthy adult subjects].
    Lehmann KA; Huttarsch H; Schroeder B; Zech D
    Anaesthesist; 1992 Apr; 41(4):192-8. PubMed ID: 1350432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral, physiological and hormonal effects of a naloxone challenge following acute morphine pretreatment in humans.
    Higgins S; Preston K; Cone E; Henningfield J; Jaffe J
    NIDA Res Monogr; 1988; 81():202-8. PubMed ID: 3136362
    [No Abstract]   [Full Text] [Related]  

  • 34. Progress report from the NIDA Addiction Research Center Baltimore, Maryland (1984).
    Jasinski DR; Johnson RE; Hickey JE; Haertzen CA; Henningfield JE; Kumor K
    NIDA Res Monogr; 1984; 55():59-65. PubMed ID: 6443391
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute administration of buprenorphine in humans: partial agonist and blockade effects.
    Walsh SL; Preston KL; Bigelow GE; Stitzer ML
    J Pharmacol Exp Ther; 1995 Jul; 274(1):361-72. PubMed ID: 7542336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacology of cocaine smoking in humans.
    Jones RT
    NIDA Res Monogr; 1990; 99():30-41. PubMed ID: 2267012
    [No Abstract]   [Full Text] [Related]  

  • 37. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heroin intoxication in adolescents.
    Kaufman DM; Hegyi T; Duberstein JL
    Pediatrics; 1972 Nov; 50(5):746-53. PubMed ID: 4563496
    [No Abstract]   [Full Text] [Related]  

  • 39. Naloxone reversal of oxymorphone effects in dogs.
    Copland VS; Haskins SC; Patz J
    Am J Vet Res; 1989 Nov; 50(11):1854-8. PubMed ID: 2482683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An etorphine-evoked vagal reflex in rats is inhibited by naloxone, N-methylnaloxone, and SMS 201-995.
    Dashwood MR; Kiang JG; Wei ET
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):77-82. PubMed ID: 6198981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.